Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C

BMJ. 2001 Oct 20;323(7318):923-6. doi: 10.1136/bmj.323.7318.923.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Clinical Protocols
  • Critical Care / methods*
  • Databases, Factual*
  • Evidence-Based Medicine / methods*
  • Humans
  • Policy Making
  • Protein C / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins / therapeutic use
  • Sepsis / drug therapy*

Substances

  • Anticoagulants
  • Protein C
  • Recombinant Proteins